183
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Availability of the serotonin transporter in patients with alcohol dependence

, , , , , , & show all
Pages 134-142 | Received 17 Mar 2010, Accepted 21 Jun 2010, Published online: 20 Jul 2010

References

  • Acton PD, Choi SR, Hou C, Plossl K, Kung HF. 2001. Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT. J Nucl Med 42:1556–1562.
  • Arolt V, Driessen M. 1996. Alcoholism and psychiatric comorbidity in general hospital inpatients. Gen Hosp Psychiatry 18:271–277.
  • Bentue-Ferrer D, Reymann JM, Tribut O, Allain H, Vasar E, Bourin M. 2001. Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam. Eur Neuropsychopharmacol 11:41–50.
  • Brown AK, George DT, Fujita M, Liow JS, Ichise M, Hibbeln J, . 2007. PET [11C]DASB imaging of serotonin transporters in patients with alcoholism. Alcohol Clin Exp Res 31:28–32.
  • Brust P, Hesse S, Muller U, Szabo Z. 2006. Neuroimaging of the serotonin trasporter – possibilities and pitfalls. Curr Psychiatry Rev 2:111–149.
  • Chalon S, Bronquard C, Vercouillie J, Kodas E, Garreau L, Bodard S, . 2004. ADAM is an effective tool for in vivo study of serotonergic function: validation in rat models. Synapse 52:136–142.
  • Chen HT, Casanova MF, Kleinman JE, Zito M, Goldman D, Linnoila M. 1991. 3H-Paroxetine binding in brains of alcoholics. Psychiatry Res 38:293–299.
  • Choi SR, Hou C, Oya S, Mu M, Kung MP, Siciliano M, . 2000. Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain. Synapse 38:403–412.
  • Davidson KM. 1995. Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status. Br J Psychiatry 166:199–204.
  • Dhaenen H. 2001. Imaging the serotonergic system in depression. Eur Arch Psychiatry Clin Neurosci 251(Suppl 2):II76–80.
  • Endicott J, Spitzer RL. 1978. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837–844.
  • Feinn R, Nellissery M, Kranzler HR. 2005. Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 133B:79–84.
  • Fils-Aime ML, Eckardt MJ, George DT, Brown GL, Mefford I, Linnoila M. 1996. Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry 53:211–216.
  • Ginovart N, Wilson AA, Meyer JH, Hussey D, Houle S. 2003. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse 47:123–133.
  • Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, . 2004. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61:807–816.
  • Haleem DJ, Batool F. 1996. Regionally specific effects of diazepam on brain serotonin metabolism in rats: sustained effects following repeated administration. Life Sci 59:PL239–246.
  • Halliday G, Ellis J, Heard R, Caine D, Harper C. 1993. Brainstem serotonergic neurons in chronic alcoholics with and without the memory impairment of Korsakoff's psychosis. J Neuropathol Exp Neurol 52:567–579.
  • Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62.
  • Hammoumi S, Payen A, Favre JD, Balmes JL, Benard JY, Husson M, . 1999. Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence? Alcohol 17:107–112.
  • Heinz A, Higley JD, Gorey JG, Saunders RC, Jones DW, Hommer D, . 1998a. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates. Am J Psychiatry 155:1023–1028.
  • Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, . 1998b. Reduced central serotonin transporters in alcoholism. Am J Psychiatry 155:1544–1549.
  • Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, . 2000. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 47:643–649.
  • Heinz A, Jones DW, Gorey JG, Bennet A, Suomi SJ, Weinberger DR, . 2003. Serotonin transporter availability correlates with alcohol intake in non-human primates. Mol Psychiatry 8:231–234.
  • Heinz A, Jones DW, Zajicek K, Gorey JG, Juckel G, Higley JD, . 2004. Depletion and restoration of endogenous monoamines affects beta-CIT binding to serotonin but not dopamine transporters in non-human primates. J Neural Transm Suppl 68:29–38.
  • Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, . 2006. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815–826.
  • Huang SY, Lin WW, Ko HC, Lee JF, Wang TJ, Chou YH, . 2004a. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res 28:374–384.
  • Huang WS, Ma KH, Cheng CY, Chen CY, Fu YK, Chou YH, et al. 2004b. Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates. Nucl Med Commun 25:515–519.
  • Huang SY, Lin WW, Wan FJ, Chang AJ, Ko HC, Wang TJ, . 2007. Monoamine oxidase–A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci 32:185–192.
  • Kish SJ, Furukawa Y, Chang LJ, Tong J, Ginovart N, Wilson A, et al. 2005. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol 32:123–128.
  • Kweon YS, Lee HK, Lee CT, Lee KU, Pae CU. 2005. Association of the serotonin transporter gene polymorphism with Korean male alcoholics. J Psychiatr Res 39:371–376.
  • LeMarquand D, Pihl RO, Benkelfat C. 1994. Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 36:326–337.
  • Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, . 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527–1531.
  • Lichtermann D, Hranilovic D, Trixler M, Franke P, Jernej B, Delmo CD, . 2000. Support for allelic association of a polymorphic site in the promoter region of the serotonin transporter gene with risk for alcohol dependence. Am J Psychiatry 157:2045–2047.
  • Lin SC, Wu PL, Ko HC, Wu JY, Huang SY, Lin WW, . 2007. Specific personality traits and dopamine, serotonin genes in anxiety-depressive alcoholism among Han Chinese in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 31:1526–1534.
  • Lundquist P, Wilking H, Hoglund AU, Sandell J, Bergstrom M, Hartvig P, . 2005. Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies. Nucl Med Biol 32:129–136.
  • Mann JJ. 1999. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21:99–105S.
  • Mantere T, Tupala E, Hall H, Sarkioja T, Rasanen P, Bergstrom K, . 2002. Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects: a whole-hemisphere autoradiography study. Am J Psychiatry 159:599–606.
  • Martinez D, Slifstein M, Gil R, Hwang DR, Huang Y, Perez A, et al. 2009. Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence. Biol Psychiatry 65:175–180.
  • Matsushita S, Yoshino A, Murayama M, Kimura M, Muramatsu T, Higuchi S. 2001. Association study of serotonin transporter gene regulatory region polymorphism and alcoholism. Am J Med Genet 105:446–450.
  • Meyer JH. 2007. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 32:86–102.
  • Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, . 2004. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 61:1271–1279.
  • Naranjo CA, Chu AY, Tremblay LK. 2002. Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction. Neurotoxicity Res 4:343–361.
  • Newberg AB, Amsterdam JD, Wintering N, Ploessl K, Swanson RL, Shults J, . 2005. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. J Nucl Med 46:973–977.
  • Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang YY, . 2006. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 163:48–51.
  • Praschak-Rieder N, Wilson AA, Hussey D, Carella A, Wei C, Ginovart N, . 2005. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol Psychiatry 58: 825–830.
  • Praschak-Rieder N, Kennedy J, Wilson AA, Hussey D, Boovariwala A, Willeit M, . 2007. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol Psychiatry 62:327–331.
  • Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, . 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. J Am Med Assoc 264:2511–2518.
  • Reimold M, Smolka MN, Schumann G, Zimmer A, Wrase J, Mann K, . 2007. Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. J Neural Transm 114:635–639.
  • Serretti A, Kato M, De Ronchi D, Kinoshita T. 2007. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 12:247–257.
  • Staley JK, Malison RT, Innis RB. 1998. Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression. Biol Psychiatry 44:534–549.
  • Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, . 2001. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41:275–284.
  • Stockmeier CA. 2003. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 37: 357–373.
  • Storvik M, Tiihonen J, Haukijarvi T, Tupala E. 2006. Lower serotonin transporter binding in caudate in alcoholics. Synapse 59:144–151.
  • Storvik M, Tiihonen J, Haukijarvi T, Tupala E. 2007. Amygdala serotonin transporters in alcoholics measured by whole hemisphere autoradiography. Synapse 61:629–636.
  • Storvik M, Haukijarvi T, Tupala E, Tiihonen J. 2008. Correlation between the SERT binding densities in hypothalamus and amygdala in Cloninger type 1 and 2 alcoholics. Alcohol Alcohol 43:25–30.
  • Swendsen JD, Merikangas KR, Canino GJ, Kessler RC, Rubio-Stipec M, Angst J. 1998. The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Compr Psychiatry 39:176–184.
  • Szabo Z, Owonikoko T, Peyrot M, Varga J, Mathews WB, Ravert HT, . 2004. Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism. Biol Psychiatry 55:766–771.
  • Talbot PS, Frankle WG, Hwang DR, Huang Y, Suckow RF, Slifstein M, . 2005. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans. Synapse 55:164–175.
  • Wendland JR, Lesch KP, Newman TK, Timme A, Gachot-Neveu H, Thierry B, . 2006. Differential functional variability of serotonin transporter and monoamine oxidase a genes in macaque species displaying contrasting levels of aggression-related behavior. Behav Genet 36:163–172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.